"More home monitoring" to counter white-coat syndrome
This article was originally published in Clinica
It is time to stop using high blood pressure readings documented by general practitioners to make treatment decisions." This is the conclusion of UK research into alternative ways of monitoring blood pressure, which finds that measurements by doctors are likely to be significantly higher than those made in a home or ambulatory setting - thereby providing an inaccurate diagnosis and a worse prediction of response to treatment and adverse outcomes.
You may also be interested in...
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.
The Stark Law ban on self-referrals wouldn’t apply to some physician owners of advanced imaging facilities under a CMS final rule.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.